Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Göran Öjteg
Robalzotan (NAD-299), a Novel Selective 5-Ht 1A Receptor Antagonist
CNS Drug Reviews
Related publications
Treatment of Hypertension With Ketanserin, a New Selective 5-Ht2 Receptor Antagonist.
BMJ
AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder
British Journal of Pharmacology
Pharmacology
Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
5-Ht3 Receptor Antagonism by Anpirtoline, a Mixed 5-Ht1 Receptor Agonist/5-Ht3 Receptor Antagonist
British Journal of Pharmacology
Pharmacology
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Characterization of Binding, Functional Activity and Contractile Responses of the Selective 5‐HT 1F Receptor Agonist Lasmiditan
British Journal of Pharmacology
Pharmacology
Effect of a Selective 5-Ht Reuptake Inhibitor in Combination With 5-HT1Aand 5-HT1Breceptor Antagonists on Extracellular 5-Ht in Rat Frontal Cortexin Vivo
British Journal of Pharmacology
Pharmacology
Anandamide, an Endogenous Cannabinoid Receptor Ligand, Also Interacts With 5-Hydroxytryptamine (5-Ht) Receptor.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Idalopirdine, a Selective 5-Ht6 Receptor Antagonist, Reduces Food Intake and Body Weight in a Model of Excessive Eating
Metabolic Brain Disease
Biochemistry
Molecular Neuroscience
Neurology
Cellular
